CTT PHARMACEUTICAL HOLDINGS, INC. purchased $187 of CTTH
CTT PHARMACEUTICAL HOLDINGS, INC. (CEO) purchased 3,400 shares of CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) at $0.06 on 2026-09-28.
CTT PHARMACEUTICAL HOLDINGS, INC.
CTT PHARMACEUTICAL HOLDINGS, INC. (CEO) purchased 3,400 shares of CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) at $0.06 on 2026-09-28.
CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. Item 8.01 Other Events. CTT Pharmaceutical Holdings, Inc. (OTCQB:CTTH) has added Karen Larson as an Independent Board Member. Mrs. Larson is a Certified Financial Planner(CFP) and has experience in running companies. Karen cre
CTT PHARMACEUTICAL HOLDINGS, INC. (CEO) purchased 10,100 shares of CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) at $0.04 on 2026-09-22.
Over the past 7 days, AlphAI's AI scored 1 news story mentioning CTTH (CTT PHARMACEUTICAL HOLDINGS, INC.). Coverage has been balanced: 0 bullish, 1 neutral, and 0 bearish.
Recent CTTH coverage spans insider activity and corporate actions.
In the last 30 days, CTTH insiders filed 7 SEC Form 4 transactions — 7 purchases ($2K) and no sales. The most active reporter was CTT PHARMACEUTICAL HOLDINGS, INC., CEO, with 7 filings.
Minor insider purchase likely signals confidence but size is negligible.
Board appointment may improve governance and strategic oversight.
Small insider purchase signals confidence but size is negligible for price.
Insider buying signals confidence and may support short-term price appreciation.
Minor insider purchase with negligible market impact.
AlphAI scores every news story that mentions CTTH with an AI model for sentiment and relevance, and aggregates insider trades from CTT PHARMACEUTICAL HOLDINGS, INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
CTT PHARMACEUTICAL HOLDINGS, INC. (CEO) purchased 3,400 shares of CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) at $0.06 on 2026-09-28.
1 min readCTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. Item 8.01 Other Events. CTT Pharmaceutical Holdings, Inc. (OTCQB:CTTH) has added Karen Larson as an Independent Board Member. Mrs. Larson is a Certified Financial Planner(CFP) and has experience in running companies. Karen cre
1 min readCTT PHARMACEUTICAL HOLDINGS, INC. (CEO) purchased 10,100 shares of CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) at $0.04 on 2026-09-22.
1 min readCTT PHARMACEUTICAL HOLDINGS, INC. (CEO) purchased 10,900 shares of CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) at $0.05 on 2026-09-16.
1 min readCTT PHARMACEUTICAL HOLDINGS, INC. (CEO) purchased 3,500 shares of CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) at $0.05 on 2026-09-10.
1 min readCTT PHARMACEUTICAL HOLDINGS, INC. (CEO) purchased 9,800 shares of CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) at $0.05 on 2026-09-04.
1 min readCTT PHARMACEUTICAL HOLDINGS, INC. (CEO) purchased 3,000 shares of CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) at $0.05 on 2026-09-02.
1 min readCTT PHARMACEUTICAL HOLDINGS, INC. (CEO) purchased 3,500 shares of CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) at $0.05 on 2026-08-31.
1 min readCTT PHARMACEUTICAL HOLDINGS, INC. (CEO) purchased 2,100 shares of CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) at $0.06 on 2026-08-24.
1 min readCTT PHARMACEUTICAL HOLDINGS, INC. (CEO) purchased 11,500 shares of CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) at $0.04 on 2026-08-20.
1 min read